• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary €“ Chart on Market Overview
o Exhibit 02: Executive Summary €“ Data Table on Market Overview
o Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
o Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary €“ Chart on Incremental Growth
o Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
o Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global insomnia therapeutics market 2017 – 2021
o Exhibit 18: Historic Market Size €“ Data Table on global insomnia therapeutics market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size €“ Type Segment 2017 – 2021 ($ million)
o 4.3 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size €“ Distribution channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size €“ Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size €“ Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Drug – Market size and forecast 2022-2027
o Exhibit 34: Chart on Drug – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Drug – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Drug – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Drug – Year-over-year growth 2022-2027 (%)
o 6.4 Devices – Market size and forecast 2022-2027
o Exhibit 38: Chart on Devices – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Devices – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Devices – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Devices – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Prescription – Market size and forecast 2022-2027
o Exhibit 48: Chart on Prescription – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Prescription – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Prescription – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Prescription – Year-over-year growth 2022-2027 (%)
o 7.4 OTC – Market size and forecast 2022-2027
o Exhibit 52: Chart on OTC – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on OTC – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on OTC – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on OTC – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ million)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Asia – Market size and forecast 2022-2027
o Exhibit 67: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.5 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 83: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 Japan – Market size and forecast 2022-2027
o Exhibit 87: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 91: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Germany – Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Astellas Pharma Inc.
o Exhibit 107: Astellas Pharma Inc. – Overview
o Exhibit 108: Astellas Pharma Inc. – Product / Service
o Exhibit 109: Astellas Pharma Inc. – Key news
o Exhibit 110: Astellas Pharma Inc. – Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 111: Aurobindo Pharma Ltd. – Overview
o Exhibit 112: Aurobindo Pharma Ltd. – Product / Service
o Exhibit 113: Aurobindo Pharma Ltd. – Key offerings
o 12.5 Eisai Co. Ltd.
o Exhibit 114: Eisai Co. Ltd. – Overview
o Exhibit 115: Eisai Co. Ltd. – Business segments
o Exhibit 116: Eisai Co. Ltd. – Key offerings
o Exhibit 117: Eisai Co. Ltd. – Segment focus
o 12.6 Electromedical Products International Inc.
o Exhibit 118: Electromedical Products International Inc. – Overview
o Exhibit 119: Electromedical Products International Inc. – Product / Service
o Exhibit 120: Electromedical Products International Inc. – Key offerings
o 12.7 Idorsia Pharmaceuticals Ltd.
o Exhibit 121: Idorsia Pharmaceuticals Ltd. – Overview
o Exhibit 122: Idorsia Pharmaceuticals Ltd. – Product / Service
o Exhibit 123: Idorsia Pharmaceuticals Ltd. – Key offerings
o 12.8 INNOVATIVE NEUROLOGICAL DEVICES LLC
o Exhibit 124: INNOVATIVE NEUROLOGICAL DEVICES LLC – Overview
o Exhibit 125: INNOVATIVE NEUROLOGICAL DEVICES LLC – Product / Service
o Exhibit 126: INNOVATIVE NEUROLOGICAL DEVICES LLC – Key offerings
o 12.9 Merck and Co. Inc.
o Exhibit 127: Merck and Co. Inc. – Overview
o Exhibit 128: Merck and Co. Inc. – Business segments
o Exhibit 129: Merck and Co. Inc. – Key news
o Exhibit 130: Merck and Co. Inc. – Key offerings
o Exhibit 131: Merck and Co. Inc. – Segment focus
o 12.10 Minerva Neurosciences Inc.
o Exhibit 132: Minerva Neurosciences Inc. – Overview
o Exhibit 133: Minerva Neurosciences Inc. – Product / Service
o Exhibit 134: Minerva Neurosciences Inc. – Key offerings
o 12.11 Neurim Pharmaceuticals Ltd.
o Exhibit 135: Neurim Pharmaceuticals Ltd. – Overview
o Exhibit 136: Neurim Pharmaceuticals Ltd. – Product / Service
o Exhibit 137: Neurim Pharmaceuticals Ltd. – Key offerings
o 12.12 Pfizer Inc.
o Exhibit 138: Pfizer Inc. – Overview
o Exhibit 139: Pfizer Inc. – Product / Service
o Exhibit 140: Pfizer Inc. – Key news
o Exhibit 141: Pfizer Inc. – Key offerings
o 12.13 Sanofi
o Exhibit 142: Sanofi – Overview
o Exhibit 143: Sanofi – Business segments
o Exhibit 144: Sanofi – Key news
o Exhibit 145: Sanofi – Key offerings
o Exhibit 146: Sanofi – Segment focus
o 12.14 Sumitomo Pharma Co. Ltd.
o Exhibit 147: Sumitomo Pharma Co. Ltd. – Overview
o Exhibit 148: Sumitomo Pharma Co. Ltd. – Business segments
o Exhibit 149: Sumitomo Pharma Co. Ltd. – Key offerings
o Exhibit 150: Sumitomo Pharma Co. Ltd. – Segment focus
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 151: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 152: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 153: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 154: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 155: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 156: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 157: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.17 Vanda Pharmaceuticals Inc.
o Exhibit 158: Vanda Pharmaceuticals Inc. – Overview
o Exhibit 159: Vanda Pharmaceuticals Inc. – Product / Service
o Exhibit 160: Vanda Pharmaceuticals Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 161: Inclusions checklist
o Exhibit 162: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 163: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 164: Research methodology
o Exhibit 165: Validation techniques employed for market sizing
o Exhibit 166: Information sources
o 13.5 List of abbreviations
o Exhibit 167: List of abbreviations

Exhibits:
Exhibits1: Executive Summary €“ Chart on Market Overview
Exhibits2: Executive Summary €“ Data Table on Market Overview
Exhibits3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits6: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary €“ Chart on Incremental Growth
Exhibits8: Executive Summary €“ Data Table on Incremental Growth
Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size €“ Data Table on global insomnia therapeutics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size €“ Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size €“ Distribution channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size €“ Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size €“ Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Drug – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Drug – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Drug – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Drug – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Devices – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Devices – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Devices – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Devices – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Prescription – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Prescription – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Prescription – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Prescription – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on OTC – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on OTC – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on OTC – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on OTC – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Astellas Pharma Inc. – Overview
Exhibits108: Astellas Pharma Inc. – Product / Service
Exhibits109: Astellas Pharma Inc. – Key news
Exhibits110: Astellas Pharma Inc. – Key offerings
Exhibits111: Aurobindo Pharma Ltd. – Overview
Exhibits112: Aurobindo Pharma Ltd. – Product / Service
Exhibits113: Aurobindo Pharma Ltd. – Key offerings
Exhibits114: Eisai Co. Ltd. – Overview
Exhibits115: Eisai Co. Ltd. – Business segments
Exhibits116: Eisai Co. Ltd. – Key offerings
Exhibits117: Eisai Co. Ltd. – Segment focus
Exhibits118: Electromedical Products International Inc. – Overview
Exhibits119: Electromedical Products International Inc. – Product / Service
Exhibits120: Electromedical Products International Inc. – Key offerings
Exhibits121: Idorsia Pharmaceuticals Ltd. – Overview
Exhibits122: Idorsia Pharmaceuticals Ltd. – Product / Service
Exhibits123: Idorsia Pharmaceuticals Ltd. – Key offerings
Exhibits124: INNOVATIVE NEUROLOGICAL DEVICES LLC – Overview
Exhibits125: INNOVATIVE NEUROLOGICAL DEVICES LLC – Product / Service
Exhibits126: INNOVATIVE NEUROLOGICAL DEVICES LLC – Key offerings
Exhibits127: Merck and Co. Inc. – Overview
Exhibits128: Merck and Co. Inc. – Business segments
Exhibits129: Merck and Co. Inc. – Key news
Exhibits130: Merck and Co. Inc. – Key offerings
Exhibits131: Merck and Co. Inc. – Segment focus
Exhibits132: Minerva Neurosciences Inc. – Overview
Exhibits133: Minerva Neurosciences Inc. – Product / Service
Exhibits134: Minerva Neurosciences Inc. – Key offerings
Exhibits135: Neurim Pharmaceuticals Ltd. – Overview
Exhibits136: Neurim Pharmaceuticals Ltd. – Product / Service
Exhibits137: Neurim Pharmaceuticals Ltd. – Key offerings
Exhibits138: Pfizer Inc. – Overview
Exhibits139: Pfizer Inc. – Product / Service
Exhibits140: Pfizer Inc. – Key news
Exhibits141: Pfizer Inc. – Key offerings
Exhibits142: Sanofi – Overview
Exhibits143: Sanofi – Business segments
Exhibits144: Sanofi – Key news
Exhibits145: Sanofi – Key offerings
Exhibits146: Sanofi – Segment focus
Exhibits147: Sumitomo Pharma Co. Ltd. – Overview
Exhibits148: Sumitomo Pharma Co. Ltd. – Business segments
Exhibits149: Sumitomo Pharma Co. Ltd. – Key offerings
Exhibits150: Sumitomo Pharma Co. Ltd. – Segment focus
Exhibits151: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits152: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits153: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits154: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits155: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits156: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits157: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits158: Vanda Pharmaceuticals Inc. – Overview
Exhibits159: Vanda Pharmaceuticals Inc. – Product / Service
Exhibits160: Vanda Pharmaceuticals Inc. – Key offerings
Exhibits161: Inclusions checklist
Exhibits162: Exclusions checklist
Exhibits163: Currency conversion rates for US$
Exhibits164: Research methodology
Exhibits165: Validation techniques employed for market sizing
Exhibits166: Information sources
Exhibits167: List of abbreviations